Mepenzolate Oral Tablet

Brand(s)
Cantil
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Sanofi-Aventis U.S. Llc (2012-03-20)
Oldest Current Product
1956-11-14
License(s)
NDA
RxNORM
ORAL TABLET\MEPENZOLATE
FDAOB
ORAL\SOLUTION\MEPENZOLATE BROMIDE
ORAL\TABLET\MEPENZOLATE BROMIDE
SPL Active
ORAL\TABLET\MEPENZOLATE BROMIDE
SPL Moiety
ORAL\TABLET\MEPENZOLATE

product(s) by strength(s)

mepenzolate 25 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000680037CantilNDASanofi-Aventis U.S. Llc1956-11-14MEPENZOLATE BROMIDEORALTABLETNDA01067971b7afe6-4625-4467-adb7-510769da2b17

application(s)

#idtitleapplicantapproved drug
1NDA010679CANTILSANOFI AVENTIS US LLCNDA010679_003, NDA010679_004

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapplication
1NDA010679_003RXMEPENZOLATE BROMIDE (25MG)ORALTABLETTrueCANTIL
2NDA010679_004discontinuedMEPENZOLATE BROMIDE (25MG/5ML)ORALSOLUTIONFalseCANTIL

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
171b7afe6-4625-4467-adb7-510769da2b17 (view SPL)CANTIL (mepenzolate bromide USP)prescriptionHuman PrescriptionSanofi-Aventis U.S. LlcANALYSIS, LABEL, MANUFACTURE, PACK2012-03-206000680037

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII